Completed NA INTERVENTIONAL 1-arm NCT03591367

The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation

Sponsor: Mansoura University

Conditions Bladder Cancer Bladder Disease Bladder Neoplasm Micro-RNA

Interventions Human telomerase reverse transcriptase MicroRNAs-155

Updated 6 times since 2018 Last updated: Nov 1, 2019 Started: Aug 1, 2018 Primary completion: May 1, 2019 Completion: May 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Bladder Cancer and Bladder Disease, this trial is completed. The trial is conducted by Mansoura University and has accumulated 6 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 1 earlier version

Aug 2018 — Dec 2019 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mansoura University

Data source: Mansoura University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Al Mansurah, Egypt